Evidence map›Paper›PMID 20737221›Full record

ArticleMolecular imaging and biology2011

In vitro evaluation of magnetic resonance imaging contrast agents for labeling human liver cells: implications for clinical translation.

Nathanael Raschzok, David A Muecke, Michaela K Adonopoulou, Nils Billecke, Wiebke Werner, Nora N Kammer, Anja Zielinski, Peter A Behringer, Frauke Ringel, Mao D Huang and 3 more

Abstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Implementation of sodium alginate-FeScientific reports · 2022
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nathanael RaschzokGeneral, Visceral, and Transplantation Surgery, Experimental Surgery and Regenerative Medicine, Charité-Campus Virchow, Universitätsmedizin Berlin, Berlin, Germany. nathanael.raschzok@charite.de
David A Muecke
Michaela K Adonopoulou
Nils Billecke
Wiebke Werner
Nora N Kammer
Anja Zielinski
Peter A Behringer
Frauke Ringel
Mao D Huang
Peter Neuhaus
Ulf Teichgräber
Igor M Sauer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMagnetic resonance imaging (MRI) is a promising approach for non-invasive monitoring after liver cell transplantation. We compared in vitro labeling of human liver cells with nano-sized (SPIO) and micron-sized iron oxide particles (MPIO). PROCEDURES: The cellular iron load was quantified and phantom studies were performed using 3.0-T MRI. Transferrin receptor and ferritin gene expression, reactive oxygen species (ROS) formation, transaminase leakage, and urea synthesis were investigated over 6 days.

resultsIncubation with MPIO produced stronger signal extinctions in MRI at similar iron loads within shorter labeling time. MPIO had no negative effects on the cellular iron homeostasis or cell performance, whereas SPIO caused temporary ROS formation and non-physiologic activation of the iron metabolic pathway.

conclusionsOur findings suggest that MPIO are suited for clinical translation of strategies for cellular imaging with MRI. Attention should be paid to iron release and oxidative stress caused by biodegradable contrast agents.

Indexed as

Staining and LabelingTranslational Research, BiomedicalContrast MediaFerritinsFerrosoferric OxideGene Expression RegulationHepatocytesHumansIronLiverMagnetic Resonance ImagingMiddle AgedReactive Oxygen SpeciesReceptors, TransferrinContrast MediaFerritinsFerrosoferric OxideIronReactive Oxygen SpeciesReceptors, Transferrin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.